Journal of Clinical Endocrinology & Metabolism, Vol 80, 2567-2573, Copyright © 1995 by Endocrine Society

ARTICLES

Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry

B van der Auwera, F Schuit, I Lyaruu, A Falorni, S Svanholm, CL Vandewalle and FK Gorus
Department of Biochemistry, Vrije Universiteit Brussel, Belgium.

Whether genetic susceptibility for insulin-dependent diabetes mellitus (IDDM) at the 5' insulin gene polymorphic region (5' INS) interacts with human leukocyte antigen (HLA)-DQ-linked disease risk and whether it is associated with autoantibody formation is presently controversial. Diabetes registries allow more systematic reassessment of these questions. Two hundred and ninety-six Caucasian IDDM patients were recruited by the Belgian Diabetes Registry and sampled at disease onset, together with 195 ethnically matched control subjects. 5'INS genotypes were determined by Southern blotting, HLA-DQ by allele- specific oligotyping, and autoantibodies by validated immunoassays. The 5' INS 1/1 genotype was more prevalent in patients than in controls [relative risk (RR) = 2.3; P < 10(-4)]. Regardless of age at onset, the 5' INS 1/1 genotype occurred less frequently in patients with the high- risk genotype DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 than in patients without it (P < 0.04). The RR associated with this high-risk HLA-DQ genotype (24.9; P < 10(-6)) was not affected by the presence or absence of the 5' INS 1/1 genotype. Combined positivity for the 5' INS 1/1 genotype and for one of three other HLA-DQ genotypes associated with an intermediate risk for IDDM conferred an age-independent RR of 12.1 (P < 10(-4)). In the absence of the 5' INS 1/1 genotype, intermediate-risk HLA-DQ genotypes no longer conferred a significant risk (2.9; not significantly different from 1). In subjects carrying neutral, protective, or infrequent HLA-DQ genotypes, the overall RR for IDDM was significantly lower than 1 (0.2; P < 10(-6)) in the absence of the 5' INS 1/1 genotype but not in its presence (0.8; not significantly different from 1). The 5' INS 1/1 genotype was not preferentially associated with immune markers for IDDM. In conclusion, regardless of age at onset and the presence of autoantibodies, 5' INS polymorphisms contribute preferentially to IDDM susceptibility in subjects without the highest HLA-DQ-associated risk.

This article has been cited by other articles:

				C. Motzo, D. Contu, H. J. Cordell, R. Lampis, M. Congia, M. G. Marrosu, J. A. Todd, M. Devoto, and F. Cucca Heterogeneity in the Magnitude of the Insulin Gene Effect on HLA Risk in Type 1 Diabetes Diabetes, December 1, 2004; 53(12): 3286 - 3291. [Abstract] [Full Text] [PDF]

				A. REWERS, S. BABU, T. B. WANG, T. L. BUGAWAN, K. BARRIGA, G. S. EISENBARTH, and H. A. ERLICH Ethnic Differences in the Associations between the HLA-DRB1*04 Subtypes and Type 1 Diabetes Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 301 - 309. [Abstract] [Full Text] [PDF]

				S. S. Rich and P. Concannon Challenges and Strategies for Investigating the Genetic Complexity of Common Human Diseases Diabetes, December 1, 2002; 51(90003): S288 - 294. [Abstract] [Full Text] [PDF]

				I. Weets, V. Siraux, J.-C. Daubresse, I. H. De Leeuw, F. Fery, B. Keymeulen, G. Krzentowski, M. Letiexhe, C. Mathieu, F. Nobels, et al. Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2597 - 2605. [Abstract] [Full Text] [PDF]

				C. E. M. De Block, I. H. De Leeuw, K. Decochez, F. Winnock, J. Van Autreve, C. M. Van Campenhout, M. Martin, and F. K. Gorus The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4358 - 4363. [Abstract] [Full Text] [PDF]

				F. Winnock, M. R. Christie, M. R. Batstra, H.-J. Aanstoot, I. Weets, K. Decochez, P. Jopart, D. Nicolaij, and F. K. Gorus Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane-Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies Diabetes Care, July 1, 2001; 24(7): 1181 - 1186. [Abstract] [Full Text] [PDF]